---
figid: PMC9553876__41420_2022_1206_Fig2_HTML
figtitle: Molecular pathway changes caused by TTFields combined with radiotherapy
  or drugs in GBM, MPM, NSCLC, and breast cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetus cricetus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC9553876
filename: 41420_2022_1206_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9553876/figure/Fig2/
number: F2
caption: A Lung cancer or MPM. A Aa–c TTFields combined with radiation causes DNA
  damage but reduces DNA damage repair by inhibiting the expression of FANCA, FANCD2,
  FANCJ, and BRCA. A Ad In addition, TTFields promotes the phosphorylation of AKT,
  which in turn promotes the phosphorylation of FOXO3A, reduces the nuclear entry
  of FOXO3A, and inhibits the expression of BIM, which ultimately leads to the weakening
  of the efficacy of Osimertinib. B Breast cancer. B Ba TTFields enhances breast cancer
  sensitivity to Trastuzumab by inhibiting AKT phosphorylation. C Glioblastoma. C
  Ca TTFields inhibits the phosphorylation of AKT, JUN, P38, and ERK, resulting in
  enhanced radiosensitivity while inhibiting ciliogenesis and enhancing the sensitivity
  of GBM to Temozolomide. C Cb In addition, TTFields combined with Sorafenib or hyperthermia
  resulted in cell death by inhibiting STAT3. C Cc TTFields inhibits ciliogenesis,
  thereby suppressing sensitivity to Temozolomide.
papertitle: The schemes, mechanisms and molecular pathway changes of Tumor Treating
  Fields (TTFields) alone or in combination with radiotherapy and chemotherapy.
reftext: Guilong Tanzhu, et al. Cell Death Discov. 2022;8:416.
year: '2022'
doi: 10.1038/s41420-022-01206-y
journal_title: Cell Death Discovery
journal_nlm_ta: Cell Death Discov
publisher_name: Nature Publishing Group UK
keywords: Cancer therapy | CNS cancer | Non-small-cell lung cancer | Autophagy | Apoptosis
automl_pathway: 0.953429
figid_alias: PMC9553876__F2
figtype: Figure
redirect_from: /figures/PMC9553876__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9553876__41420_2022_1206_Fig2_HTML.html
  '@type': Dataset
  description: A Lung cancer or MPM. A Aa–c TTFields combined with radiation causes
    DNA damage but reduces DNA damage repair by inhibiting the expression of FANCA,
    FANCD2, FANCJ, and BRCA. A Ad In addition, TTFields promotes the phosphorylation
    of AKT, which in turn promotes the phosphorylation of FOXO3A, reduces the nuclear
    entry of FOXO3A, and inhibits the expression of BIM, which ultimately leads to
    the weakening of the efficacy of Osimertinib. B Breast cancer. B Ba TTFields enhances
    breast cancer sensitivity to Trastuzumab by inhibiting AKT phosphorylation. C
    Glioblastoma. C Ca TTFields inhibits the phosphorylation of AKT, JUN, P38, and
    ERK, resulting in enhanced radiosensitivity while inhibiting ciliogenesis and
    enhancing the sensitivity of GBM to Temozolomide. C Cb In addition, TTFields combined
    with Sorafenib or hyperthermia resulted in cell death by inhibiting STAT3. C Cc
    TTFields inhibits ciliogenesis, thereby suppressing sensitivity to Temozolomide.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mtln
  - H2-Aa
  - App
  - H2-Ab1
  - Fancd2
  - Brca1
  - ac
  - Brip1
  - Fanca
  - Akt1
  - Ad
  - Foxo3
  - Bcl2l11
  - ba
  - Pik3r1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Jun
  - Ephb2
  - Mapk1
  - Stat3
  - MTLN
  - APP
  - SUCLA2
  - FANCD2
  - BRCA1
  - BRIP1
  - FANCA
  - AKT1
  - AKT2
  - AKT3
  - FOXO3
  - BCL2L11
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - JUN
  - JUNB
  - JUND
  - EPHB2
  - MAPK3
  - STAT3
  - Errfi1
  - Pik3cg
  - Ephb1
  - Prm
  - aa
  - ab
  - Appl
  - Akt
  - ad
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ca
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Jra
  - cb
  - Erk7
  - rl
---
